Funding you earn now, next payment 01:00 UTC+0.0090%/8h= +9.9% APRnext payment +$0.11 per $10,000 · paid last 24h +0.024%
Price spread now: Injective against Arcus+10.198%7-day average — · you sell dearer than you buy
to open and closeno order booka leg has no order-book sample
Funding, last 3 days (all we have)—no history yet
+Price spread, last 7 days—no price history on both exchanges yet
=Together, before fees—needs both histories
Both sides work for this trade now. Funding pays +$3 a day on $10k at the current rate, and Injective is 10.198% dearer against Arcus than usual: you sell high and buy low: +$1,020 more if the spread goes back to zero (this spread has no 7-day history yet).
| Leg | Exchange | Price | Funding /8h | Each payment | Next in | OI | Vol 24h | Max lev |
|---|---|---|---|---|---|---|---|---|
| Long | Arcus GLD-USD | 400.09 | 0.0130 | pay 0.0016% / 1h | 36m 42s | $292K | $483K | 25x |
| Short | Injective GLD/USDC PERP | 440.89 | 0.0220 | get 0.0028% / 1h | 36m 42s | $3K | $92 | 52x |
Funding history
latest
Range statsloading…
Price spread between the two exchanges
Injective against Arcus. Falling: the short leg gains. Rising: it loses.latest
Price spreadloading…
Funding on every exchange
click an exchange to add or hide itlatest
How often the price spread is this wide · share of time at each level, last 7D show
Profit calculator
- Funding earned
- $18.93
- Price spread: +10.198% → 0.000%
- $1,019.77
- Slippage, 4 orders
- no order book: not counted
- Fee Arcus: 2.25 bp × 2 orders
- −$4.5
- Fee Injective: 0.01 bp × 2 orders
- −$0.02
- Net
- $1,034.18
- Costs to cover
- 0.045%
- Break-even
- from the start
Slippage unknown: Arcus: live order book, 37 min ago; Injective: no order-book sample. Net counts fees only.
Cost to enter
taker fee + slippage from the mid, one side; closing costs about the same again| Leg | Half-spread | $10k | $100k | $1M | $5M |
|---|---|---|---|---|---|
| Buy Arcus live order book, 37 min ago | 2.50 bp | 6.0 bp −$6 | 7.1 bp −$71 | 23.2 bp −$2,319 | doesn't fit |
| Sell Injective no order-book sample | — | — | — | — | — |
Injective: no order-book sample. Either the market is below $100k of open interest and volume (not sampled), or the venue executes at an oracle price and its slippage is not modeled here: see the venue's docs.
GLD on 5 venues
lowest funding first. Swap a leg: a good short leg pays more funding and is priced higher.| Exchange | Funding /8h | Every | Price | Price vs long leg | OI | Vol 24h | Max lev | |
|---|---|---|---|---|---|---|---|---|
| Gate GLD_USDT | 0.0000% | 8h | 400.00 | −0.022% | $48K | $3K | 20x | as long as short |
| Vest GLD-USD-PERP | +0.0046% | 1h | 399.71 | −0.095% | — | — | 25x | as long as short |
| Arcus GLD-USDlong | +0.0130% | 1h | 400.09 | long leg | $292K | $483K | 25x | |
| MEXC GLD_USDT | +0.0200% | 8h | 399.79 | −0.075% | $110K | $97K | 20x | as long as short |
| Injective GLD/USDC PERPshort | +0.0220% | 1h | 440.89 | +10.198% | $3K | $92 | 52x |
Injective GLD/USDC PERP
Gate GLD_USDT
MEXC GLD_USDT